Morgan, a ketamine researcher and the head of ketamine-assisted therapy at Awakn Life Sciences (NEO: AWKN) (OTCMKTS: AWKNF), was named one of the most influential women shaping the future of the psychedelics industry in a recent Business Insider article.
Last week The Dales Report sat down with her to discuss her work on ketamine, her role at Awakn, and how Awakn’s KARE Program (that is, Ketamine in the Reduction of Alcohol Relapse), was developed to help people reduce their reliance on and consumption of alcohol.
__________________________________________________________
Timestamps:
0:00 Intro
0:44 Awakn’s Head Of Ketamine Therapy Celia Morgan Background
1:43 How Awakn Is Tackling Alcoholism?
11:31 Changing The Relationship With A Behaviour
13:09 Finalizin
__________________________________________________________
About Channel:
We are a business news platform that provides the latest and best insight on the stories making headlines around the world. We give Institutional and retail investors an inside edge in the competitive world of investing and profile companies that are making waves in their ever-growing industries.
We are The Dales Report.
Check out our website: [ Ссылка ]
Subscribe to our channel at [ Ссылка ]
Connect with us on our social media handles:
Twitter: [ Ссылка ]
Instagram: [ Ссылка ]
Tiktok: [ Ссылка ]
Facebook: [ Ссылка ]
TDR Contributors Instagram:
Nicolle Hodges: [ Ссылка ]
Anthony Varrell: [ Ссылка ]
Amanda Siebert: [ Ссылка ]
__________________________
The Dales Report Inc. disclosure policy applies to this video: [ Ссылка ]
